A viral video captured a tense moment in the Oval Office during a White House press conference on Thursday, when Gordon Findlay, a Novo Nordisk executive, suddenly collapsed. This incident raised questions about Robert F. Kennedy Jr.'s response at the event hosted by President Donald Trump.
The press conference aimed to announce a new partnership between the government and pharmaceutical companies Eli Lilly and Novo Nordisk to reduce obesity drug costs for millions of Americans. What began as a major policy announcement quickly turned chaotic when Findlay lost his balance and collapsed near the Resolute Desk while President Trump was speaking.
Mehmet Oz, the Administrator of the Centers for Medicare & Medicaid Services, promptly assisted Findlay, helping him avoid serious injury. Following the incident, the press was swiftly removed from the room to manage the emergency.
"Video shows Gordon Findlay, Novo Nordisk Global Brand Director, losing his balance and collapsing beside the Resolute Desk while President Trump spoke."
The unexpected collapse during a high-profile event generated significant media attention and social media speculation, particularly concerning Robert F. Kennedy Jr.'s reaction as the Secretary of Health and Human Services.
The sudden medical emergency at a key government announcement prompted immediate action from officials and sparked public scrutiny over responses from health authorities.
"The person who collapsed was Novo Nordisk Global Brand Director Gordon Findlay. He was in the Oval Office to discuss a weight loss drug partnership."
Author’s summary: A Novo Nordisk executive’s collapse during a White House announcement caused chaos and controversy, focusing attention on health officials’ reactions amid talks on obesity drug pricing.